Nocturnal Hypoglycaemia Progression in People with Insulin-Treated Type 2 Diabetes Tags Hypoglycemia Read more about Nocturnal Hypoglycaemia Progression in People with Insulin-Treated Type 2 Diabetes
Severe Hypoglycemia Risk in Type 1 Diabetes Linked to Low Glucose Time and Impaired Awareness Tags Hypoglycemia Read more about Severe Hypoglycemia Risk in Type 1 Diabetes Linked to Low Glucose Time and Impaired Awareness
Lower Estimated Glucose Disposal Rate Linked to Higher First Myocardial Infarction Risk in Diabetes Read more about Lower Estimated Glucose Disposal Rate Linked to Higher First Myocardial Infarction Risk in Diabetes
Two Type 1 Diabetes-Specific Models Show Strong Agreement in Predicting 10-Year Cardiovascular Risk Read more about Two Type 1 Diabetes-Specific Models Show Strong Agreement in Predicting 10-Year Cardiovascular Risk
SCORE2-Diabetes Accurately Predicts Cardiovascular Risk in Type 1 Diabetes Read more about SCORE2-Diabetes Accurately Predicts Cardiovascular Risk in Type 1 Diabetes
Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes
SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes
SGLT2 Inhibitors Linked to Higher Phimosis Risk in Men with Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Higher Phimosis Risk in Men with Type 2 Diabetes
New Erythrocytosis Increases Coronary Risk in Type 2 Diabetes Patients Read more about New Erythrocytosis Increases Coronary Risk in Type 2 Diabetes Patients
Once-Weekly GZR4 Demonstrates Comparable Efficacy to Daily Insulin Degludec in Type 2 Diabetes Read more about Once-Weekly GZR4 Demonstrates Comparable Efficacy to Daily Insulin Degludec in Type 2 Diabetes
